Bal Pharma Balance Sheet Health
Financial Health criteria checks 2/6
Bal Pharma has a total shareholder equity of ₹687.6M and total debt of ₹1.5B, which brings its debt-to-equity ratio to 225.4%. Its total assets and total liabilities are ₹3.4B and ₹2.7B respectively. Bal Pharma's EBIT is ₹224.8M making its interest coverage ratio 1.8. It has cash and short-term investments of ₹247.2M.
Key information
225.4%
Debt to equity ratio
₹1.55b
Debt
| Interest coverage ratio | 1.8x |
| Cash | ₹247.15m |
| Equity | ₹687.58m |
| Total liabilities | ₹2.71b |
| Total assets | ₹3.40b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524824's short term assets (₹2.5B) exceed its short term liabilities (₹2.2B).
Long Term Liabilities: 524824's short term assets (₹2.5B) exceed its long term liabilities (₹500.4M).
Debt to Equity History and Analysis
Debt Level: 524824's net debt to equity ratio (189.4%) is considered high.
Reducing Debt: 524824's debt to equity ratio has increased from 205.1% to 225.4% over the past 5 years.
Debt Coverage: 524824's debt is not well covered by operating cash flow (19.6%).
Interest Coverage: 524824's interest payments on its debt are not well covered by EBIT (1.8x coverage).